The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

Su‐Ni Tang(The University of Kansas Cancer Center), Rakesh K. Srivastava(Northwell Health)

Journal of Molecular Signaling

August 18, 2010

10.1186/1750-2187-5-14

Cited by 221

Related Papers

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition

|PLoS ONE|2011|301

Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

|International Journal of Oncology|2007|235

Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory

|European Journal of Medicinal Chemistry|2018|217

Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer

|Oncotarget|2014|192

PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

|Oncotarget|2015|160